A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Efficacy, Safety and Tolerability of MT 7117 in Adults and Adolescents with Erythropoietic Protoporphyria or X Linked Protoporphyria

  • Anderson, Karl (PI)

Project: Other project

Project Details

StatusFinished
Effective start/end date9/17/205/14/21